Please check your internet connection and try again.
# Attopamezol
## Overview
Attopamezol is an alpha-2 adrenergic antagonist.
## Primary Indications
Attopamezol is indicated for the reversal of sedation and analgesia induced by alpha-2 adrenergic agonists (e.g., xylazine, detomidine, medetomidine, romifidine) in animals.
## Adult Dosing
* **General:** Dosing is highly dependent on the specific alpha-2 agonist used, the dose administered, and the desired speed of reversal.
* **For xylazine reversal:** Typically administered at a dose of 0.2 mg/kg intravenously (IV), intramuscularly (IM), or subcutaneously (SC).
* **For detomidine or medetomidine reversal:** Typically administered at a dose of 0.1 mg/kg IV, IM, or SC.
* **Maximum Dose:** Not explicitly defined, but titrate to effect.
## Pediatric Dosing
Specific pediatric dosing for attopamezol is not established. Dosing in juvenile animals should be based on weight and careful consideration of physiological differences.
## Dose Adjustments
* **Renal Impairment:** No specific dose adjustments are typically recommended, but caution is advised.
* **Hepatic Impairment:** No specific dose adjustments are typically recommended, but caution is advised.
* **Titration:** The dose may need to be adjusted based on the patient's response to achieve the desired level of arousal.
## Contraindications
* Hypersensitivity to attopamezol.
* Use in animals not sedated or not receiving analgesia from an alpha-2 adrenergic agonist.
## Adverse Effects
Common adverse effects include:
* Transient muscle tremors
* Increased heart rate (tachycardia)
* Sudden arousal leading to excitement or aggression
* Increased respiratory rate
* Salivation
* Potential for regurgitation or vomiting
* Hypotension may occur in some cases, though less common than with the agonists.
## Key Drug Interactions
* **Alpha-2 Adrenergic Agonists:** Attopamezol is designed to antagonize these agents. Concurrent use may lead to unpredictable effects.
* **Other Sedatives/Anesthetics:** May potentiate or antagonize the effects of other central nervous system depressants.
## Monitoring
* Cardiovascular parameters (heart rate, blood pressure)
* Respiratory rate and depth
* Level of consciousness and arousal
* Presence of muscle tremors or excitement
## Clinical Pearls
* Administer attopamezol when reversal of sedation/analgesia is desired.
* The onset of action is rapid, especially with IV administration.
* Careful patient observation is crucial due to the potential for sudden and vigorous arousal.
* A repeat dose may be necessary if adequate reversal is not achieved.
* Always confirm the specific alpha-2 agonist used and its corresponding recommended reversal dose.
***
*Disclaimer: This information is intended for clinical pharmacists and healthcare professionals. Always consult the most current prescribing information and institutional protocols before administering any medication. This information does not replace professional judgment.*
